EUVIMEDEUVIMED entdecken
Open Access

Creation and preclinical evaluation of a novel mussel-inspired, biomimetic, bioactive bone graft scaffold: direct comparison with Infuse bone graft using a rat model of spinal fusion

Ethan Cottrill, Zach Pennington, Matthew T Wolf, Naomi Dirckx, Jeff Ehresman, Alexander Perdomo-Pantoja, Christian Rajkovic, Jessica Lin, David R Maestas, Ashlie Mageau, Dennis Lambrechts, Veronica Stewart und 4 weitere

Journal of Neurosurgery: Spine · 2023

DOI: 10.3171/2023.2.spine22936 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurosurgery: Spine, 2023. Verfasst von Ethan Cottrill und 15 weiteren Autor:innen. Beteiligte Einrichtung: Departments of1Neurosurgery. Hauptthemen laut MEDLINE: Spinal Fusion. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE Infuse bone graft is a widely used osteoinductive adjuvant; however, the simple collagen sponge scaffold used in the implant has minimal inherent osteoinductive properties and poorly controls the delivery of the adsorbed recombinant human bone morphogenetic protein–2 (rhBMP-2). In this study, the authors sought to create a novel bone graft substitute material that overcomes the limitations of Infuse and compare the ability of this material with that of Infuse to facilitate union following spine surgery in a clinically translatable rat model of spinal fusion. METHODS The authors created a polydopamine (PDA)–infused, porous, homogeneously dispersed solid mixture of extracellular matrix and calcium phosphates (BioMim-PDA) and then compared the efficacy of this material directly with Infuse in the setting of different concentrations of rhBMP-2 using a rat model of spinal fusion. Sixty male Sprague Dawley rats were randomly assigned to each of six equal groups: 1) collagen + 0.2 µg rhBMP-2/side, 2) BioMim-PDA + 0.2 µg rhBMP-2/side, 3) collagen + 2.0 µg rhBMP-2/side, 4) BioMim-PDA + 2.0 μg rhBMP-2/side, 5) collagen + 20 µg rhBMP-2/side, and 6) BioMim-PDA + 20 µg rhBMP-2/side. All animals underwent posterolateral intertransverse process fusion at L4–5 using the assigned bone graft. Animals were euthanized 8 weeks postoperatively, and their lumbar spines were analyzed via microcomputed tomography (µCT) and histology. Spinal fusion was defined as continuous bridging bone bilaterally across the fusion site evaluated via µCT. RESULTS The fusion rate was 100% in all groups except group 1 (70%) and group 4 (90%). Use of BioMim-PDA with 0.2 µg rhBMP-2 led to significantly greater results for bone volume (BV), percentage BV, and trabecular number, as well as significantly smaller trabecular separation, compared with the use of the collagen sponge with 2.0 µg rhBMP-2. The same results were observed when the use of BioMim-PDA with 2.0 µg rhBMP-2 was compared with the use of the collagen sponge with 20 µg rhBMP-2. CONCLUSIONS Implantation of rhBMP-2–adsorbed BioMim-PDA scaffolds resulted in BV and bone quality superior to that afforded by treatment with rhBMP-2 concentrations 10-fold higher implanted on a conventional collagen sponge. Using BioMim-PDA (vs a collagen sponge) for rhBMP-2 delivery could significantly lower the amount of rhBMP-2 required for successful bone grafting clinically, improving device safety and decreasing costs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spinal FusionMaleRatsHumansAnimalsBone TransplantationX-Ray MicrotomographyBiomimeticsRats, Sprague-DawleyTransforming Growth Factor betaBone Morphogenetic Protein 2CollagenRecombinant ProteinsLumbar Vertebrae

Stichwörter der Autor:innen

animal modelsbone graftsbone tissue engineeringrhBMP-2spinal fusionsurgical technique

Substanzen

Transforming Growth Factor betaBone Morphogenetic Protein 2CollagenRecombinant Proteins

Autor:innen und Institutionen

  • Departments of1Neurosurgery.
  • 3Department of Orthopaedic Surgery, Duke University Health System, Durham, North Carolina.
  • 4Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota.
  • 2Biomedical Engineering, and.
  • 5Laboratory of Cancer Immunometabolism, Center for Cancer Research, National Cancer Institute, Frederick, Maryland.
  • 6Orthopaedic Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Förderung

  • Intramural NIH HHS

Zitieren

APA

Cottrill, E., Pennington, Z., Wolf, M. T., Dirckx, N., Ehresman, J., Perdomo-Pantoja, A., Rajkovic, C., Lin, J., Maestas, D. R., Mageau, A., Lambrechts, D., Stewart, V., Sciubba, D. M., Theodore, N., Elisseeff, J. H., & Witham, T. (2023). Creation and preclinical evaluation of a novel mussel-inspired, biomimetic, bioactive bone graft scaffold: direct comparison with Infuse bone graft using a rat model of spinal fusion. Journal of Neurosurgery: Spine. https://doi.org/10.3171/2023.2.spine22936

Vancouver

Cottrill E, Pennington Z, Wolf MT, Dirckx N, Ehresman J, Perdomo-Pantoja A, et al. Creation and preclinical evaluation of a novel mussel-inspired, biomimetic, bioactive bone graft scaffold: direct comparison with Infuse bone graft using a rat model of spinal fusion. Journal of Neurosurgery: Spine. 2023. doi:10.3171/2023.2.spine22936

BibTeX
@article{Cottrill2023,
  author = {Cottrill, Ethan and Pennington, Zach and Wolf, Matthew T and Dirckx, Naomi and Ehresman, Jeff and Perdomo-Pantoja, Alexander and Rajkovic, Christian and Lin, Jessica and Maestas, David R and Mageau, Ashlie and Lambrechts, Dennis and Stewart, Veronica and Sciubba, Daniel M and Theodore, Nicholas and Elisseeff, Jennifer H and Witham, Timothy},
  title = {Creation and preclinical evaluation of a novel mussel-inspired, biomimetic, bioactive bone graft scaffold: direct comparison with Infuse bone graft using a rat model of spinal fusion},
  journal = {Journal of Neurosurgery: Spine},
  year = {2023},
  doi = {10.3171/2023.2.spine22936}
}
Kostenlos starten →